Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.0001 per share
-
Shares outstanding
-
126M
-
Number of holders
-
130
-
Total 13F shares, excl. options
-
53.4M
-
Shares change
-
-2.22M
-
Total reported value, excl. options
-
$114M
-
Value change
-
-$5.35M
-
Put/Call ratio
-
17.71
-
Number of buys
-
68
-
Number of sells
-
-75
-
Price
-
$2.13
Significant Holders of Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) as of Q1 2023
168 filings reported holding ORGO - Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share as of Q1 2023.
Organogenesis Holdings Inc. - Class A Common Stock, par value $0.0001 per share (ORGO) has 130 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.4M shares
of 126M outstanding shares and own 42.32% of the company stock.
Largest 10 shareholders include Soleus Capital Management, L.P. (9.85M shares), BlackRock Inc. (4.49M shares), VANGUARD GROUP INC (3.71M shares), AQR CAPITAL MANAGEMENT LLC (2.55M shares), CITADEL ADVISORS LLC (2.55M shares), FEDERATED HERMES, INC. (1.89M shares), MILLENNIUM MANAGEMENT LLC (1.58M shares), GEODE CAPITAL MANAGEMENT, LLC (1.51M shares), ACADIAN ASSET MANAGEMENT LLC (1.41M shares), and Assenagon Asset Management S.A. (1.37M shares).
This table shows the top 130 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.